Skip to main content

Table 3 Safety parameters in total group during the 3-yar study

From: Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition

 

At start

After 1 year

After 2 years

After 3 years

P-value*

Fasting glucose (mmol/l)

4.6 (4.4 to 4.8)

4.7 (4.5 to 4.9)

4.8 (4.6 to 4.9)

4.6 (4.5 to 4.7)

0.93

Fasting insulin (pmol/l)

59.5 (45.2 to 81.5)

67.6 (55.0 to 81.5)

64.5 (51.6 to 78.7)

55.0 (42.4 to 69.2)

0.54

Systolic BP (mmHg)*

120.2 (116.5 to 123.9)

123.9 (120.6 to 127.1)

122.7 (118.6 to 126.8)

121.4 (116.4 to 126.3)

0.68

Diastolic BP (mmHg)*

73.1 (70.5 to 75.7)

73.0 (71.1 to 75.0)

74.3 (72.0 to 76.5)

73.6 (70.9 to 76.3)

0.78

  1. Data are expressed as estimated means (95% CI). BP Blood pressure. *corrected for sex and height
  2. *P-value of the change during 3 years of GH treatment